These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 21187601)
1. [ASBMR 2010 report. Meeting report on the ASBMR. Obstacles in medicine for osteoporosis]. Koike T Clin Calcium; 2011 Jan; 21(1):104-8. PubMed ID: 21187601 [TBL] [Abstract][Full Text] [Related]
2. [Innovations in the treatment of osteoporosis]. Tsourdi E; Hofbauer LC Dtsch Med Wochenschr; 2011 Dec; 136(48):2458-60. PubMed ID: 22109575 [No Abstract] [Full Text] [Related]
3. [ASBMR 2010 report. Meeting report on the ASBMR: clinical topics in ASBMR 2010 at Toronto]. Okazaki R Clin Calcium; 2011 Jan; 21(1):112-5. PubMed ID: 21187603 [TBL] [Abstract][Full Text] [Related]
4. Increasing options for the treatment of osteoporosis. Khosla S N Engl J Med; 2009 Aug; 361(8):818-20. PubMed ID: 19671654 [No Abstract] [Full Text] [Related]
5. [ASBMR 2010 report. Meeting report on the ASBMR. Present and future of the treatment of osteoporosis]. Koike T Clin Calcium; 2012 Jan; 22(1):114-8. PubMed ID: 22201108 [TBL] [Abstract][Full Text] [Related]
6. Osteoporosis medications and your dental health. J Am Dent Assoc; 2011 Nov; 142(11):1320. PubMed ID: 22041419 [No Abstract] [Full Text] [Related]
7. New approaches to the treatment of osteoporosis. Silva BC; Bilezikian JP Annu Rev Med; 2011; 62():307-22. PubMed ID: 21054170 [TBL] [Abstract][Full Text] [Related]
8. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. Wensel TM; Iranikhah MM; Wilborn TW Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432 [TBL] [Abstract][Full Text] [Related]
9. Denosumab, osteoporosis, and prevention of fractures. Kyrgidis A N Engl J Med; 2009 Nov; 361(22):2189; author reply 2190-1. PubMed ID: 19950409 [No Abstract] [Full Text] [Related]
13. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ]. Mashiba T Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033 [TBL] [Abstract][Full Text] [Related]
14. [[Antiresorptive agents in the treatment of osteoporosis]. Novak S Reumatizam; 2014; 61(2):89-94. PubMed ID: 25427401 [TBL] [Abstract][Full Text] [Related]
15. Short-term and long-term effects of osteoporosis therapies. Reid IR Nat Rev Endocrinol; 2015 Jul; 11(7):418-28. PubMed ID: 25963272 [TBL] [Abstract][Full Text] [Related]
16. [Drugs under development for osteoporosis ]. Masuda H; Tanaka S Nihon Rinsho; 2009 May; 67(5):980-4. PubMed ID: 19432120 [TBL] [Abstract][Full Text] [Related]
17. Denosumab an option for patients with bone metastasis from breast cancer. Barton MK CA Cancer J Clin; 2011; 61(3):135-6. PubMed ID: 21532096 [No Abstract] [Full Text] [Related]
18. Antiresorptive drugs beyond bisphosphonates and selective oestrogen receptor modulators for the management of postmenopausal osteoporosis. Reginster JY; Neuprez A; Beaudart C; Lecart MP; Sarlet N; Bernard D; Disteche S; Bruyere O Drugs Aging; 2014 Jun; 31(6):413-24. PubMed ID: 24797286 [TBL] [Abstract][Full Text] [Related]
19. Atypical femoral fractures and their relation to bisphosphonate use. Tripto-Shkolnik L Isr Med Assoc J; 2013 Aug; 15(8):447-50. PubMed ID: 24079069 [No Abstract] [Full Text] [Related]